A61K 38 - Medicinal preparations containing peptides

Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2009
11/19/2009	CA2724540A1 Treating dyspnea associated with acute heart failure with relaxin
11/19/2009	CA2724535A1 Method of treating chronic heart failure
11/19/2009	CA2724534A1 Pharmaceutical compositions of somatostatin-dopamine conjugates
11/19/2009	CA2724483A1 Treatment for epilepsy
11/19/2009	CA2724384A1 Treatment of metastatic tumors
11/19/2009	CA2724352A1 Collagen peptide conjugates and uses therefor
11/19/2009	CA2724308A1 Method of promoting wound healing
11/19/2009	CA2724277A1 Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis
11/19/2009	CA2724198A1 Novel and powerful mhc-class ii petptides derived from survivin
11/19/2009	CA2724173A1 Methods of detecting cells with a disrupted cell membrane, cells infected with a pathogen, dying cells or dead cells
11/19/2009	CA2724052A1 Pharmaceutical composition for the treatment of dry eye and/or corneal and conjunctival lesion
11/19/2009	CA2724048A1 Oral preparation
11/19/2009	CA2723994A1 Angiogenin-enriched milk fractions
11/19/2009	CA2723987A1 Use of angiogenin or angiogenin agonists for treating diseases and disorders
11/19/2009	CA2723946A1 Molecules interfering with binding of calbindin to inositol monophosphatase for the treatment of mood disorders
11/19/2009	CA2723855A1 Long-acting y2 and/or y4 receptor agonists
11/19/2009	CA2723833A1 Methods and compositions for the treatment of obesity
11/19/2009	CA2723621A1 Treatment of hearing and balance impairments using compounds having erythropoietin activity
11/19/2009	CA2723170A1 Peptides, peptidomimetics and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	CA2722960A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	CA2722959A1 Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
11/19/2009	CA2722600A1 Anti-hepcidin antibodies and methods of use
11/19/2009	CA2721362A1 Site-directed modification of factor ix
11/19/2009	CA2720523A1 Treatment of bladder dysfunction using liposomal botulinum toxin
11/18/2009	EP2119793A1 Methods for producing modified glycoproteins
11/18/2009	EP2119785A1 Novel peptides
11/18/2009	EP2119784A2 Method and compositions for cellular reprogramming
11/18/2009	EP2119778A1 Method for activation of helper t cell and composition for use in the method
11/18/2009	EP2119728A1 Therapeutic and diagnostic agents
11/18/2009	EP2119726A1 Novel and powerful MHC-class II peptides derived from survivin and neurocan
11/18/2009	EP2119450A2 Induction of mucosal tolerance to antigens
11/18/2009	EP2119449A1 Hgf preparation
11/18/2009	EP2119448A1 High affinity binding site of HGFR and methods for identification of antagonists thereof
11/18/2009	EP2119445A1 Prophylactic agent for autoimmune disease
11/18/2009	EP2119436A1 Pharmaceutical compositions for preventing and treating eye pathologies
11/18/2009	EP2119371A2 Animal feeds and veterinary compositions
11/18/2009	EP2118272A2 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts
11/18/2009	EP2118137A2 New peptides and polypeptides with improved stability useful in the regeneration of the nervous system
11/18/2009	EP2118136A2 Consensus peptide
11/18/2009	EP2118134A1 Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof
11/18/2009	EP2118133A2 Amelioration of cellular stress response
11/18/2009	EP2118127A2 Nitrogen-based linkers for attaching modifying groups to polypeptides and other macromolecules
11/18/2009	EP2118080A1 Macrocyclic ghrelin receptor modulators and methods of using the same
11/18/2009	EP2117620A1 Tropoelastin-based protoelastin biomaterials
11/18/2009	EP2117582A2 Periostin induces proliferation of cardiomyocytes and promotes cardiac regeneration
11/18/2009	EP2117581A1 Wnt3a for inhibition of scarring
11/18/2009	EP2117580A1 Use of wnt3a for acceleration of wound healing
11/18/2009	EP2117579A1 Treating cancer with granulocyte-macrophage colony stimulating factor
11/18/2009	EP2117577A1 G protein-coupled receptor and modulators thereof for the treatment of gaba-related neurological disorders including sleep-related disorders
11/18/2009	EP2117576A1 Methods and compositions related to inhibition of viral entry
11/18/2009	EP2117575A2 Methods and compositions related to clot binding compounds
11/18/2009	EP2117574A2 Polypeptides for inducing a protective immune response against staphylococcus epidermidis
11/18/2009	EP2117573A2 Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
11/18/2009	EP2117572A2 New fusion molecule based on novel taa variant
11/18/2009	EP2117571A2 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
11/18/2009	EP2117541A1 Compounds and compositions as channel activating protease inhibitors
11/18/2009	EP2117528A2 Use of adenosine deaminase for treating pulmonary disease
11/18/2009	EP2117514A1 Compositions comprising peg- interferon alpha conjugates and raffinose as cryoprotectant
11/18/2009	EP2117510A1 Parenteral pharmaceutical composition and method for preparing the same
11/18/2009	EP2117330A1 Process for the preparation of angiogenin
11/18/2009	EP2117303A2 Methods for treating psoriasis
11/18/2009	EP1711518B1 Chimpanzee adenovirus vaccine carriers
11/18/2009	EP1572961B1 Actriib fusion polypeptides and uses therefor
11/18/2009	EP1572148B1 Cosmetic composition comprising a siegesbeckia extract and a lipopeptide
11/18/2009	EP1543122B1 Bitter taste receptors
11/18/2009	EP1499349B1 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen
11/18/2009	EP1463541B1 Biomaterials based on hyaluronic acid benzyl ester for the anti-angiogenic therapy in the treatment of tumours
11/18/2009	EP1458425B1 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis
11/18/2009	EP1451552B1 Reagents and methods useful for detecting diseases of the breast
11/18/2009	EP1207873B1 Methods of inhibiting osteoclast activity
11/18/2009	EP1079875B2 Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons
11/18/2009	EP0960127B1 Isolated dimeric fibroblast activation protein alpha, and uses thereof
11/18/2009	EP0957901B1 Pharmaceutical preparations of glutathione and methods of administration thereof
11/18/2009	EP0914422B1 Mammalian genes involved in viral infection
11/18/2009	EP0904112B1 Composition comprising il-1ra as interleukin-1 inhibitor and hyaluronan as controlled release polymer
11/18/2009	EP0758904B1 Methods and compositions for the treatment of glomerulonephritis
11/18/2009	EP0662133B1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
11/18/2009	CN101583375A Crystallized oxalate decarboxylase and methods of use
11/18/2009	CN101583374A Anti-cocaine compositions and treatment
11/18/2009	CN101583373A Therapeutic agent for interstitial pneumonia
11/18/2009	CN101583372A HCV NS3 protease inhibitors
11/18/2009	CN101583371A RNAi methods and compositions for stimulating proliferation of cells with adherent junctions
11/18/2009	CN101583370A Proteinaceous pharmaceuticals and uses thereof
11/18/2009	CN101583346A Fusogenic properties of saposin C and related proteins and peptides for application to transmembrane drug delivery systems
11/18/2009	CN101580548A Fusion peptide for inhibiting tumor growth and application thereof in preparing anti-tumor medicament
11/18/2009	CN101580547A HASylated polypeptides, especially HASylated erythropoietin
11/18/2009	CN101580539A Polypeptide for inducing CD4CD25 regulatory T cells and application
11/18/2009	CN101580538A WT1-origin HLA-DR-binding antigen peptide
11/18/2009	CN101580536A Macrocyclic ns-3 serine protease inhibitors of hepatitis c virus comprising alkyl and aryl alanine p2 moieties
11/18/2009	CN101580535A Hcv protease inhibitors
11/18/2009	CN101579529A Oligonucleotide compositions and method for treating disease including inflammatory conditions
11/18/2009	CN101579522A Novel peptide-based vaccine used for domestic animal and preparation method thereof
11/18/2009	CN101579520A Aplidine for the treatment of multiple myeloma
11/18/2009	CN101579362A Compositions and method for tumor-target delivery of effect molecules
11/18/2009	CN100561229C A cytocapacity test
11/18/2009	CN100560723C Recombinant human sCTLA4-Ig fusion protein gene and its medicinal composition
11/18/2009	CN100560720C Methods of delivery of exogenous proteins to the cytosol and uses thereof
11/18/2009	CN100560601C Derivative of cyclosporins C and D and pharmaceutical composition thereof
11/18/2009	CN100560130C Tumor antigen based on products of the tumor suppressor gent WT1
11/18/2009	CN100560129C Use of inhibitors of enzymes with APN and/or DPIV activity for the treatment of dermatological diseases involving the hyperproliferation and modified differentiation conditions of fibroblasts

1 ... 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 ... 3163